Piramal Enterprises Ltd.’s Pharma Solutions business is investing ~CAD$25 million to expand its Aurora facility in Canada with the addition of a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients (APIs). The Piramal Pharma Solutions’ (PPS) Aurora facility will enhance its offerings with the addition of ~10,500 sq.-ft. of new manufacturing space that will support the facility’s ability to provide APIs and HPAPIs down to an Occupational Exposure Limit (OEL) ...